Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00010504 · ClinicalTrials.gov registry record · Phase 3

Acupuncture in Fibromyalgia

A Phase 3 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).

Completed
Registry status
Phase 3
Development phase

NCT00010504: Completed Phase 3 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).

NCT00010504 is a Phase 3 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00010504, a Phase 3 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).

COMPLETED
Registry status
Phase 3
Development phase

Study Summary

Fibromyalgia is the second most common rheumatic disorder, affecting approximately 8-10 million persons in the U.S., and is characterized by widespread musculoskeletal pain and soft tissue tenderness upon examination. This study focuses on the use of acupuncture as a mode of therapy for fibromyalgia. The issues under examination are: 1) the optimal duration of treatment, 2) the independent and synergistic effects of needle placement and needle stimulation, and 3) appropriate control strategies. The proposal utilizes a randomized, blinded, sham-controlled design to achieve these aims. Subjects are randomly assigned to one of four groups: 1)active site with stimulation, 2) active site, without stimulation, 3) sham site with stimulation, and 4) sham site, without stimulation. All subjects will receive acupuncture at escalating frequency, beginning at once per week and ending at 3 times per week. This "forced titration" design allows for the detection of inter-subject differences in responsiveness to acupuncture, as well as the factors which may predict responsiveness (or lack thereof). Secondary goals of the study are to collect data on the mechanism, safety, and cost-effectiveness of acupuncture in fibromyalgia, and to determine the optimal outcome measures, for a full scale research clinical trial.

Interventions

  • PROCEDURE Acupuncture

Trial Details

FieldValue
Start Date 2000-08
Est. Completion 2003-07
Phase Phase 3

What the finished NCT00010504 record still lists

NCT00010504 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 1 intervention - of which Acupuncture is the first listed.

NCT00010504 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00010504 about?

NCT00010504 is a clinical study titled "Acupuncture in Fibromyalgia". Fibromyalgia is the second most common rheumatic disorder, affecting approximately 8-10 million persons in the U.S., and is characterized by widespread musculoskeletal pain and soft tissue tenderness upon examination. This study focuses on the use of acupuncture as a mode of therapy for fibromyalgia...

What is the current status of trial NCT00010504?

This trial is currently completed. It is a Phase 3 study. The study started on 2000-08. Estimated completion is 2003-07.

What interventions are being tested in trial NCT00010504?

The interventions under investigation include: Acupuncture (PROCEDURE).

Who is sponsoring clinical trial NCT00010504?

This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00010504, the US trial registry maintained by the National Library of Medicine. NCT00010504 (unsized enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.